Catalyst Wire Dossier Catalyst Wire Dossier

PF-07321332

nirmatrelvir · Pfizer
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PF-07321332, covering 2023-08-02 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants. [Phase 1]

See pricing